0001209191-23-056522.txt : 20231122 0001209191-23-056522.hdr.sgml : 20231122 20231122175129 ACCESSION NUMBER: 0001209191-23-056522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wagner Paul A. CENTRAL INDEX KEY: 0001612842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 231434625 MAIL ADDRESS: STREET 1: C/O PFENEX INC. STREET 2: 10790 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (310) 618-6994 MAIL ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-20 0 0001419041 Forte Biosciences, Inc. FBRX 0001612842 Wagner Paul A. C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BLDG 6 DALLAS TX 75247 1 1 0 0 See Remarks 0 Common Stock 2023-11-20 4 P 0 5300 0.44 A 1709671 D Common Stock 2023-11-20 4 P 0 1566 0.43 A 1711237 D Common Stock 2023-11-20 4 P 0 100 0.4251 A 1711337 D Common Stock 2023-11-22 4 P 0 400 0.43 A 1711737 D CEO, Secretary and Chair of the Board /s/ Paul A. Wagner, Ph.D. 2023-11-22